FDA halts use of monoclonal antibody drugs from Regeneron, Eli Lilly that don't work vs. omicron

France Nouvelles Nouvelles

FDA halts use of monoclonal antibody drugs from Regeneron, Eli Lilly that don't work vs. omicron
France Dernières Nouvelles,France Actualités
  • 📰 ABC7Chicago
  • ⏱ Reading Time:
  • 41 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 63%

The FDA revoked emergency authorization for COVID-19 monoclonal antibody drugs from Regeneron and Eli Lilly for being ineffective against omicron.

WASHINGTON -- COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health regulators said Monday.

Omicron's resistance to the two leading monoclonal antibody medicines has upended the treatment playbook for COVID-19 in recent weeks. The FDA noted in its decision that omicron accounts for more than 99% of U.S. infections, making it"highly unlikely" the antibodies would help people now seeking treatment. The agency said restricting their use would also eliminate unnecessary drug side effects, including allergic reactions.

The drugs are not a substitute for vaccination and are generally reserved for people who are the most vulnerable, including seniors, transplant recipients and those with conditions like heart disease and diabetes. The move comes days after regulators broadened the use of remdesivir - the first drug approved for COVID-19 - to treat more patients.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

ABC7Chicago /  🏆 284. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

FDA halts use of monoclonal antibody drugs from Regeneron, Eli Lilly that don't work vs. omicronFDA halts use of monoclonal antibody drugs from Regeneron, Eli Lilly that don't work vs. omicronCOVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant, U.S. health officials said.
Lire la suite »

Eli Apple torpedoes Giants, Saints in unfiltered tweetstormEli Apple torpedoes Giants, Saints in unfiltered tweetstormBengals cornerback Eli Apple wrapped up his playoff weekend by dumping on his former teams, the Giants and Saints.
Lire la suite »

Across The Shield: Eli Apple Makes Game-Changing Pass Deflection, Nick Bosa Sacks Aaron Rodgers Twice As Bengals, 49ers Make Conference Championship GamesAcross The Shield: Eli Apple Makes Game-Changing Pass Deflection, Nick Bosa Sacks Aaron Rodgers Twice As Bengals, 49ers Make Conference Championship GamesEli Apple makes a game-changing pass deflection and Nick Bosa sacks Aaron Rodgers twice as the Bengals and 49ers pull off upset wins to advance to conference championship games.
Lire la suite »

Skull Session: Jim Tressel Dumps on Jim Harbaugh, Ohio State Owns the AP Poll, and Eli Apple's Personality Has Come AliveSkull Session: Jim Tressel Dumps on Jim Harbaugh, Ohio State Owns the AP Poll, and Eli Apple's Personality Has Come AliveSkull Session: Jim Tressel gives Jim Harbaugh a 1-star review, Ohio State owns the AP Poll, Eli Apple's had an incredible heel turn, and more.
Lire la suite »

FDA halts use of monoclonal antibody drugs from Regeneron, Eli Lilly that don't work vs. omicronFDA halts use of monoclonal antibody drugs from Regeneron, Eli Lilly that don't work vs. omicronCOVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant, U.S. health officials said.
Lire la suite »

FDA halts use of antibody drugs that don't work against omicronFDA halts use of antibody drugs that don't work against omicronCOVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don’t work against the omicron variant. Doctors have alternate therapies, including two new antiviral pills from Pfizer and Merck, but both are in short supply.
Lire la suite »



Render Time: 2025-04-11 11:02:41